Last reviewed · How we verify
NCT06284343: GynCAT
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
trial testing Anticoagulant in Cancer-associated Thrombosis in 1,800 participants. Currently enrolling.
30 September 2026
Quick facts
| Lead sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,800 |
| Start date | 15 April 2024 |
| Primary completion | 30 September 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Anticoagulant — full drug profile →
Conditions studied
- Cancer-associated Thrombosis — all drugs for Cancer-associated Thrombosis →
- Venous Thromboembolism — all drugs for Venous Thromboembolism →
- Gynecologic Cancer — all drugs for Gynecologic Cancer →
- Ovarian Cancer — all drugs for Ovarian Cancer →
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Who can join
18 and older, female only, with Cancer-associated Thrombosis or Venous Thromboembolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06284343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Anticoagulant
Trials testing the same drug.
- NCT06168838 — Anticoagulant-associated Intracranial Hemorrhage · unknown
- NCT05475080 — Carotid Web and Stroke Registry. · unknown
- NCT04847752 — Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis · recruiting
- NCT02004509 — Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial · Phase 4 · unknown
- NCT07388056 — Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population · completed
Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials
Trials by the same sponsor.
- NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
- NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
- NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
- NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
- NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06284343 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06284343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing